Adipocyte specific deletion of IL-6 does not attenuate obesity-induced weight gain or glucose intolerance in mice.

Martin Whitham; Martin Pal; Tim Petzold; Marit Hjorth; Casey L Egan; Julia S Brunner; Emma Estevez; Peter Iliades; Borivoj Zivanovic; Saskia Reibe; William E Hughes; Maria Findeisen; Juan Hidalgo; Mark A Febbraio
Abstract
It has been suggested that interleukin-6 (IL-6) produced by adipocytes in obesity leads to liver insulin resistance, although this hypothesis has never been definitively tested. Accordingly, we did so by generating adipocyte specific IL-6 deficient (AdipoIL-6) mice and studying them in the context of diet-induced and genetic obesity.-/-Mice carrying 2 floxed alleles of IL-6 (C57Bl/6J) were crossed with Cre recombinase overexpressing mice driven by the adiponectin promoter to generate AdipoIL-6 mice. AdipoIL-6 and floxed littermate controls (FL) were fed a standard chow (CHOW) or high fat diet (HFD) for 16 weeks and comprehensively metabolically phenotyped. In addition to a diet-induced obesity (DIO) model, we also examined the role of adipocyte derived IL-6 in a genetic model of obesity and insulin resistance by crossing the AdipoIL-6 mice with leptin deficient () mice.-/-As expected, mice on a HFD and mice displayed marked weight gain and increased fat mass compared with chow fed and (littermate control) animals, respectively. However, deletion of IL-6 from adipocytes in either model had no effect on glucose tolerance or fasting hyperinsulinemia.ob/obAdipocyte specific IL-6 does not contribute to whole body glucose intolerance in obese mice.
Journal AMERICAN JOURNAL OF PHYSIOLOGY. ENDOCRINOLOGY AND METABOLISM
ISSN 1522-1555
Published 06 Aug 2019
Volume
Issue
Pages
DOI 10.1152/ajpendo.00206.2019
Type Journal Article
Sponsorship